Novo Nordisk A/S (NYSE:NVO)
| 158.07 Delayed Data As of Jun 09 |  -1.38 / -0.87%Today’s Change | 95.02 Today|||52-Week Range 172.97 | +16.79% Year-to-Date |
Stock Price Forecast
The 23 analysts offering 12-month price forecasts for Novo Nordisk A/S have a median target of 180.13, with a high estimate of 208.80 and a low estimate of 103.69. The median estimate represents a +13.96% increase from the last price of 158.07.
Analyst Recommendations
The current consensus among 27 polled investment analysts is to Buy stock in Novo Nordisk A/S. This rating has held steady since May, when it was unchanged from a rating.Move your mouse over past
months for detail
Earnings and Sales Forecasts
Current Quarter
Earnings per Share
$1.28
$1.28
Sales
$7.8B
$7.8B
Reporting Date
Aug 10
Aug 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.
Growthquarterly -1.33%
Growthannually 43.06%
Sales
Growthquarterly -0.52%
Growthannually 25.13%
